Redhawk Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,099
Closed -$1.28M 319
2024
Q3
$1.28M Buy
11,099
+1,247
+13% +$141K 0.18% 110
2024
Q2
$1.05M Buy
9,852
+3,583
+57% +$360K 0.16% 122
2024
Q1
$606K Buy
6,269
+822
+15% +$84.3K 0.1% 173
2023
Q4
$550K Buy
5,447
+1,294
+31% +$125K 0.11% 162
2023
Q3
$423K Buy
+4,153
New +$422K 0.14% 131

Other funds holding NVS

Redhawk Wealth Advisors's NVS Position: Q4 2024 in Review

Redhawk Wealth Advisors sold out of Novartis (NVS) in Q4 2024, closing a stake of 11,099 shares — an estimated $1.28M sold.

Redhawk Wealth Advisors first reported a position in NVS in Q3 2023 and held it in 5 quarters. The position peaked at $1.28M in Q3 2024. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Redhawk Wealth Advisors reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 11,099 Novartis shares in Q4 2024, an estimated $1.28M.
  • Redhawk Wealth Advisors first reported a position in Novartis in Q3 2023 and held it in 5 quarters.
  • Redhawk Wealth Advisors's Novartis position peaked at $1.28M in Q3 2024.
  • 1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Redhawk Wealth Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.